Gemcitabine: A cytidine analogue active against solid tumors
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date1997/01/15
-
Indian UGC (journal)
-
Citations117
-
Yuk Fung Hui Department of Clinical Pharmacy, University of California San Francisco Medical Center, San Francisco; when this article was written she was Pharmacy Practice Resident, Department of Pharmacy Services, University of Michigan Medical Center (UMMC), Ann Arbor
-
Jeffrey Reitz Outpatient Hematology/Oncology Program, UMMC
Cite
Hui, Yuk Fung, and Jeffrey Reitz. “Gemcitabine: A Cytidine Analogue Active Against Solid Tumors”. American Journal of Health-System Pharmacy, vol. 54, no. 2, 1997, pp. 162-70, https://doi.org/10.1093/ajhp/54.2.162.
Hui, Y. F., & Reitz, J. (1997). Gemcitabine: A cytidine analogue active against solid tumors. American Journal of Health-System Pharmacy, 54(2), 162-170. https://doi.org/10.1093/ajhp/54.2.162
Hui, Yuk Fung, and Jeffrey Reitz. “Gemcitabine: A Cytidine Analogue Active Against Solid Tumors”. American Journal of Health-System Pharmacy 54, no. 2 (1997): 162-70. https://doi.org/10.1093/ajhp/54.2.162.
Hui YF, Reitz J. Gemcitabine: A cytidine analogue active against solid tumors. American Journal of Health-System Pharmacy. 1997;54(2):162-70.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Factors Associated With Burnout Among US Hospital Clinical Pharmacy Practitioners: Results of a Nationwide Pilot Survey
- Prevention and Management of Antineoplastic Extravasation Injury
- Reduction in Surface Contamination with Cyclophosphamide in 30 US Hospital Pharmacies following Implementation of a Closed-System Drug Transfer Device
- Epidemiology of Clostridium difficile Infection
- Aminoglycoside-Induced Nephrotoxicity
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer | Journal of Biological Chemistry |
| 2024 | |
The Effect of PEGylation on Drugs’ Pharmacokinetic Parameters; from
Absorption to Excretion | Current Drug Delivery |
| 2024 | |
X‐Ray Excited Luminescence Materials for Cancer Diagnosis and Theranostics | Laser & Photonics Reviews |
| 2023 | |
| Development of a magnetic solid phase extraction method for gemcitabine from rat plasma by using magnetic graphene oxide calix[6]arene composite and its application to pharmacokinetics | Separation Science and Technology |
| 2023 | |
Gemcitabine-associated DRESS syndrome: A case report | Journal of Oncology Pharmacy Practice |
| 1 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 41
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Human deoxycytidine kinase is located in the cell nucleus and was published in 1997. The most recent citation comes from a 2024 study titled Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer. This article reached its peak citation in 2016, with 8 citations. It has been cited in 90 different journals, 11% of which are open access. Among related journals, the Cancer Letters cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.